Recombinant Pig SNCA Protein，His

The study of SNCA (Alpha-synuclein) recombinant proteins has gained significant attention due to their pivotal role in neurodegenerative diseases, particularly Parkinson's disease. Alpha-synuclein is a neuronal protein that is predominantly found in the brain, where it is involved in synaptic function and neurotransmitter release. Misfolding and aggregation of SNCA into insoluble fibrils are hallmark features of Parkinson’s disease and certain other synucleinopathies, leading to the formation of Lewy bodies, which are toxic to neurons. Understanding the structure and dynamics of SNCA at the molecular level is crucial for elucidating the mechanisms underlying its pathogenesis. Researchers utilize recombinant techniques to produce SNCA protein in a controlled environment, enabling detailed studies of its biochemical properties and aggregation behavior. These investigations are essential for developing therapeutic strategies aimed at mitigating SNCA-related toxicities, such as small molecules that can prevent aggregation or enhance the natural clearance of misfolded proteins. Additionally, recombinant SNCA is instrumental in the development of animal models and in vitro systems that replicate the disease state, facilitating drug discovery and the exploration of potential interventions. Overall, the study of SNCA recombinant proteins provides critical insights into the molecular pathways of neurodegeneration and holds promise for novel therapeutic approaches in targeting synucleinopathies.